S&P 500   3,382.52 (+1.46%)
DOW   27,975.22 (+1.04%)
QQQ   272.28 (+2.67%)
AAPL   452.06 (+3.33%)
MSFT   209.86 (+3.19%)
FB   260.97 (+1.89%)
GOOGL   1,508.12 (+1.86%)
AMZN   3,161.00 (+2.61%)
NVDA   457.21 (+5.35%)
CGC   17.22 (+1.59%)
BABA   255.63 (+2.90%)
TSLA   1,558.82 (+13.42%)
GE   6.64 (-1.34%)
MU   48.53 (+1.61%)
AMD   82.05 (+6.72%)
T   30.22 (+0.07%)
F   7.10 (-1.80%)
ACB   9.78 (-2.40%)
GILD   68.89 (+1.16%)
NFLX   478.41 (+2.46%)
DIS   131.62 (+0.87%)
BAC   26.75 (-0.63%)
BA   175.28 (-2.69%)
S&P 500   3,382.52 (+1.46%)
DOW   27,975.22 (+1.04%)
QQQ   272.28 (+2.67%)
AAPL   452.06 (+3.33%)
MSFT   209.86 (+3.19%)
FB   260.97 (+1.89%)
GOOGL   1,508.12 (+1.86%)
AMZN   3,161.00 (+2.61%)
NVDA   457.21 (+5.35%)
CGC   17.22 (+1.59%)
BABA   255.63 (+2.90%)
TSLA   1,558.82 (+13.42%)
GE   6.64 (-1.34%)
MU   48.53 (+1.61%)
AMD   82.05 (+6.72%)
T   30.22 (+0.07%)
F   7.10 (-1.80%)
ACB   9.78 (-2.40%)
GILD   68.89 (+1.16%)
NFLX   478.41 (+2.46%)
DIS   131.62 (+0.87%)
BAC   26.75 (-0.63%)
BA   175.28 (-2.69%)
S&P 500   3,382.52 (+1.46%)
DOW   27,975.22 (+1.04%)
QQQ   272.28 (+2.67%)
AAPL   452.06 (+3.33%)
MSFT   209.86 (+3.19%)
FB   260.97 (+1.89%)
GOOGL   1,508.12 (+1.86%)
AMZN   3,161.00 (+2.61%)
NVDA   457.21 (+5.35%)
CGC   17.22 (+1.59%)
BABA   255.63 (+2.90%)
TSLA   1,558.82 (+13.42%)
GE   6.64 (-1.34%)
MU   48.53 (+1.61%)
AMD   82.05 (+6.72%)
T   30.22 (+0.07%)
F   7.10 (-1.80%)
ACB   9.78 (-2.40%)
GILD   68.89 (+1.16%)
NFLX   478.41 (+2.46%)
DIS   131.62 (+0.87%)
BAC   26.75 (-0.63%)
BA   175.28 (-2.69%)
S&P 500   3,382.52 (+1.46%)
DOW   27,975.22 (+1.04%)
QQQ   272.28 (+2.67%)
AAPL   452.06 (+3.33%)
MSFT   209.86 (+3.19%)
FB   260.97 (+1.89%)
GOOGL   1,508.12 (+1.86%)
AMZN   3,161.00 (+2.61%)
NVDA   457.21 (+5.35%)
CGC   17.22 (+1.59%)
BABA   255.63 (+2.90%)
TSLA   1,558.82 (+13.42%)
GE   6.64 (-1.34%)
MU   48.53 (+1.61%)
AMD   82.05 (+6.72%)
T   30.22 (+0.07%)
F   7.10 (-1.80%)
ACB   9.78 (-2.40%)
GILD   68.89 (+1.16%)
NFLX   478.41 (+2.46%)
DIS   131.62 (+0.87%)
BAC   26.75 (-0.63%)
BA   175.28 (-2.69%)
Log in

NASDAQ:AERIAerie Pharmaceuticals SEC Filings & 10K Form

$12.41
+0.11 (+0.89 %)
(As of 08/12/2020 03:03 PM ET)
Add
Compare
Today's Range
$12.03
Now: $12.41
$12.62
50-Day Range
$11.56
MA: $13.35
$15.88
52-Week Range
$10.80
Now: $12.41
$26.26
Volume25,647 shs
Average Volume773,789 shs
Market Capitalization$577.19 million
P/E RatioN/A
Dividend YieldN/A
Beta0.94

SEC Filings

Aerie Pharmaceuticals (NASDAQ:AERI) SEC Filings

DateFilerForm TypeView
08/12/2020
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
3:07 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2020
5:42 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2020
9:10 AM
Aerie Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
07/08/2020
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:35 PM
Aerie Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G/A
06/29/2020
7:06 PM
Aerie Pharmaceuticals (Issuer)
Cagle Gerald D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
7:05 PM
Aerie Pharmaceuticals (Issuer)
Croarkin Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
7:04 PM
Aerie Pharmaceuticals (Issuer)
du Toit Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
7:03 PM
Aerie Pharmaceuticals (Issuer)
GRYSKA DAVID W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
7:02 PM
Aerie Pharmaceuticals (Issuer)
MCGRAW BENJAMIN F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
7:01 PM
Aerie Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
3:31 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
2:09 PM
Aerie Pharmaceuticals (Subject)
Foresite Capital Fund II, L.P. (Filed by)
Form SC 13G/A
06/11/2020
5:45 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2020
9:04 AM
Aerie Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
05/20/2020
5:45 PM
Aerie Pharmaceuticals (Issuer)
GOLDBERG MURRAY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:46 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:45 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:44 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
4:25 PM
Aerie Pharmaceuticals (Issuer)
Cagle Gerald D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2020
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:06 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2020
3:10 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2020
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
3:35 PM
Aerie Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G
03/18/2020
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
5:32 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2020
7:05 AM
Aerie Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2020
9:20 AM
Aerie Pharmaceuticals (Subject)
HARTFORD MUTUAL FUNDS INC/CT (Filed by)
Form SC 13G/A
02/12/2020
7:02 AM
Aerie Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2020
6:29 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:25 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:19 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:14 PM
Aerie Pharmaceuticals (Issuer)
LaRocca John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:10 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
5:01 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
5:00 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
4:59 PM
Aerie Pharmaceuticals (Issuer)
LaRocca John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
4:58 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
4:57 PM
Aerie Pharmaceuticals (Issuer)
MITRO THOMAS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
6:32 AM
Aerie Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/28/2020
10:34 AM
Aerie Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/21/2020
5:43 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2020
5:41 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
5:05 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
6:03 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:06 PM
Aerie Pharmaceuticals (Issuer)
Kopczynski Casey C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
5:41 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
5:11 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:41 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
5:33 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
3:08 PM
Aerie Pharmaceuticals (Issuer)
Hollander David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:05 PM
Aerie Pharmaceuticals (Issuer)
Hollander David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/12/2019
1:52 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:10 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:04 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:04 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
6:14 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund II, L.P. (Reporting)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management II, LLC (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 3/A
11/05/2019
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2019
5:43 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
3:02 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
6:05 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2019
5:40 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
5:44 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
4:05 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
5:10 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
4:19 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
5:32 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
4:45 PM
Aerie Pharmaceuticals (Issuer)
RUBINO RICHARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
4:43 PM
Aerie Pharmaceuticals (Issuer)
ANIDO VICENTE JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
7:28 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund II, L.P. (Reporting)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management II, LLC (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
5:26 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
7:38 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund II, L.P. (Reporting)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management II, LLC (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
4:02 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
7:52 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund II, L.P. (Reporting)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management II, LLC (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
7:27 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund II, L.P. (Reporting)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management II, LLC (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
5:41 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
3:05 PM
Aerie Pharmaceuticals (Issuer)
LaRocca John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
8:30 PM
Aerie Pharmaceuticals (Subject)
Foresite Capital Fund II, L.P. (Filed by)
Form SC 13G/A
08/14/2019
7:15 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund II, L.P. (Reporting)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management II, LLC (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
7:14 PM
Aerie Pharmaceuticals (Issuer)
Foresite Capital Fund II, L.P. (Reporting)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Management II, LLC (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2019
5:30 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:04 PM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
5:32 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2019
5:42 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:37 PM
Aerie Pharmaceuticals (Subject)
Flynn James E (Filed by)
Form SC 13G
06/13/2019
5:31 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
5:34 AM
Aerie Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
9:11 AM
Aerie Pharmaceuticals (Issuer)
GOLDBERG MURRAY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
5:16 PM
Aerie Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
5:14 PM
Aerie Pharmaceuticals (Issuer)
MCGRAW BENJAMIN F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.